Large Cap High Growth Potential

Results

254

7 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

254 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	GH	US$155.87	-2.6%	235.5%	US$20.6b	US$171.08	19.1	55.8%	n/a	Healthcare
	NVDA	US$202.81	-3.9%	17.6%	US$5.0t	US$302.31	30.8	22.8%	0.5%	Semiconductors
	LITE	US$732.82	-8.6%	616.9%	US$54.9b	US$1,104.89	129.9	56.3%	n/a	Tech
	CRDO	US$202.68	-21.4%	116.8%	US$38.8b	US$276.39	80.0	27.7%	n/a	Semiconductors
	SPCX	US$123.99	-14.7%	n/a	US$1.7t	US$237.32	84.6	60.7%	n/a	Telecom
	AXSM	US$230.00	-1.6%	105.9%	US$12.2b	US$280.39	16.7	57.0%	n/a	Pharmaceuticals & Biotech
	MOD	US$229.34	-6.7%	134.6%	US$12.0b	US$340.86	100.2	49.2%	n/a	Capital Goods
	MDGL	US$553.48	3.1%	65.6%	US$12.6b	US$678.86	11.3	59.1%	n/a	Pharmaceuticals & Biotech
	SMTC	US$124.96	-8.2%	133.0%	US$11.9b	US$205.25	10.7	74.6%	n/a	Semiconductors
	ARM	US$267.19	-17.4%	70.5%	US$279.8b	US$303.97	315.7	37.0%	n/a	Semiconductors
	MRVL	US$188.68	-20.0%	152.8%	US$164.9b	US$253.69	65.4	25.9%	0.1%	Semiconductors
	AMD	US$495.76	-11.1%	215.8%	US$816.8b	US$540.19	163.9	36.2%	n/a	Semiconductors
	BE	US$214.96	-12.1%	760.2%	US$58.8b	US$283.16	10134.9	45.6%	n/a	Capital Goods
	NU	US$13.59	-1.2%	4.4%	US$67.0b	US$17.94	5.2	20.0%	n/a	Banks
	MTSI	US$267.36	-13.3%	88.1%	US$21.0b	US$404.77	115.4	34.3%	n/a	Semiconductors
	LSCC	US$125.23	-8.9%	136.1%	US$17.1b	US$148.33	863.1	60.4%	n/a	Semiconductors
	AXON	US$510.28	-9.8%	-32.5%	US$43.7b	US$660.88	199.7	22.8%	n/a	Capital Goods
	RDDT	US$181.18	-7.2%	22.2%	US$35.7b	US$226.67	49.3	25.3%	n/a	Media
	AVGO	US$370.83	-7.3%	30.9%	US$1.8t	US$524.51	60.2	33.5%	0.7%	Semiconductors
	APP	US$424.54	-16.3%	16.5%	US$146.0b	US$654.60	36.4	21.7%	n/a	Software
	CBRS	US$172.86	-19.6%	n/a	US$40.9b	US$291.09	400.7	73.7%	n/a	Semiconductors
	ALAB	US$303.62	-26.5%	197.3%	US$54.8b	US$291.33	194.5	31.8%	n/a	Semiconductors
	SITM	US$554.97	-11.8%	157.6%	US$14.9b	US$837.50	38.6	89.7%	n/a	Semiconductors
	KRYS	US$354.86	-3.0%	140.6%	US$10.1b	US$361.67	46.5	36.6%	n/a	Pharmaceuticals & Biotech

Page 1 of 8